Internal Server Error

About KittyHawk Ventures

KittyHawk Ventures is a venture capital firm founded in 2015. It is primarily based out of Santa Monica, United States. As of Jan 2024, KittyHawk Ventures has invested in 27 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and HealthTech. Most recently it participated in the $***** Series A round of Lykos Overall, KittyHawk Ventures portfolio has seen 4 acquisitions, namely Kezar Life Sciences and AMPLY. A lot of funds co-invest with KittyHawk Ventures, with names like True Ventures sharing a substantial percentage of its portfolio. KittyHawk Ventures has team of 22 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio Acquisitions
Portfolio Soonicorns

KittyHawk Ventures' List of Top Investments

KittyHawk Ventures has a portfolio of 27 companies. Their most notable investments are in MycoMedica and Xplore.Their portfolio spans across United States, Canada, Poland and 1 more locations. They have invested in Enterprise Applications, High Tech, HealthTech and 19 other sectors, across stages such as Series A, Seed  and 1 more. Here is the list of top investments by KittyHawk Ventures:
Provider of AI-powered robotic document digitization and intelligent data extraction platform. The company combines proprietary robotics with optical character recognition, natural language processing, and machine learning to scan physical records, ingest digital files, classify structured and unstructured documents, and extract searchable data at scale. Its cloud content platform lets organizations access, search, and integrate this data into systems of record, enabling automated workflows, compliance, and analytics for sectors such as financial services, manufacturing, real estate, and the public sector.

Key facts about Ripcord

Vytalize Health offers a mobile app that allows patients to book an on-demand house call at their own place. The patients are first screened by their nurse using a questionnaire to check the need for a home visit. After initial screening, a home visit is made by the doctor to the patient's convenience. Vytaliz charges a flat fee per home visit.

Key facts about Vytalize Health

1QB Information Technologies (1QBit) is a quantum computing software company which has created a hardware-agnostic platform (can be integrated with both classical and quantum computers) for performing quantum computation. Provides an API endpoint which the industry partners can integrate into their existing applications. Partnered with D-Wave Systems, its software reformulates optimization problems into the quadratic unconstrained binary optimization (QUBO) format necessary to compute with D-Wave's quantum annealing processors. The company is primarily focused on applications such as computational finance, the energy industry, and the life sciences.

Key facts about 1QBit

  • Founded Year: 2012
  • Location: Vancouver (Canada)
  • Stage: Series B
  • Total Funding till date: $45M
  • Employee Count: 51 as on Aug 31, 2026
  • Investors: Gen 1 Capital, CME Group and 17 Others
  • Latest Funding Round: Conventional Debt, Jun 29, 2018, $*****
  • Highlight: Editors' Pick
AI-powered inventory tracking and management platform. It develops autonomous indoor drones. Its features include obstacle avoidance, autonomous navigation, error management, and inventory management. It caters to the logistics and warehousing industries.

Key facts about Verity

  • Founded Year: 2014
  • Location: Zurich (Switzerland)
  • Stage: Series B
  • Total Funding till date: $76.1M
  • Employee Count: 135 as on Aug 31, 2026
  • Investors: Qualcomm Ventures, Exor and 10 Others
  • Latest Funding Round: Series B, Jul 11, 2023, $*****
  • Highlight: Editors' Pick
Developer of drugs targeting protein homeostasis for autoimmune disorders. The company develops therapies that harness master regulators of cellular function to inhibit multiple drivers of disease via single, powerful targets. The product pipeline includes KZR-616 and KZR-261 for autoimmune disease and hematologic tumor types.

Key facts about Kezar Life Sciences

KittyHawk Ventures' Investments by Stage

KittyHawk Ventures has made 7 investments in Series A stage with an average round size of $36.4M, 3 investments in Seed stage with an average round size of $7.37M and 1 investment in Series B stage with an average round size of $16.2M.
Here are KittyHawk Ventures' investments by stage:
Stage of entry
No. of Investments
Series A
7
Seed
3
Series B
1
Breakdown of KittyHawk Ventures' investments by stage of entrySeries A (7)Seed (3)
Note: We have considered here, only first round of investments

KittyHawk Ventures' Investments by Sector

KittyHawk Ventures has a diverse portfolio, with companies operating in the High Tech, Aerospace, Maritime and Defense Tech, Consumer, Enterprise Applications and Healthcare. Notably, it has invested in 22 Tech companies, 20 Enterprise (B2B) companies, 11 Software companies and at least 7 companies focusing on Saas.
Here are KittyHawk Ventures' investments by sector:
Sector
No. of Investments
High Tech
5
Aerospace, Maritime and Defense Tech
3
Consumer
3
Enterprise Applications
3
Healthcare
2
Others
13
Breakdown of KittyHawk Ventures' investments by sectorsHigh Tech (5)Aerospace, Mariti... (3)
Note: We have considered here, only first round of investments

KittyHawk Ventures' Investments by Geography

KittyHawk Ventures has made most investments in United States (10), followed by Switzerland where it has made 1 investment.
Here are KittyHawk Ventures' investments by geography:
Country
No. of Investments
United States
10
Switzerland
1
Breakdown of KittyHawk Ventures' investments by countriesUnited States (10)Switzerland (1)
Note: We have considered here, only first round of investments

KittyHawk Ventures' recent investments

KittyHawk Ventures has not made any investment in 2026 so far.
Here are the most recent investments by KittyHawk Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jan 05, 2024
United States
Series A
4521
  [+6]
Mar 06, 2023
United States
Seed
4072
Aug 30, 2022
United States
Seed
2667
Jun 01, 2022
United States
Series A
4630
Apr 11, 2022
United States
Series B
3855

Acquired companies in KittyHawk Ventures' Portfolio

4 companies from KittyHawk Ventures' portfolio have been acquired. The most recent acquisition was Kezar Life Sciences in Mar 2026 by Aurinia Pharmaceuticals for $*****.
Here are KittyHawk Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 30, 2026
-
-
9924
Aug 03, 2022
-
-
9441
Dec 07, 2021
Apr 24, 2020
Series A
2373
Feb 19, 2020
-
-
3613

Team profile of KittyHawk Ventures

KittyHawk Ventures has a team of 22 members including 2 Partners, 8 Venture Partners and 2 Principals located in United States and Italy. KittyHawk Ventures' team does not sit on the board of any company as of now.
Here is a list of top team members in KittyHawk Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
-
-
-
Partner
San Antonio
-
Venture Partner
United States
-
-
Venture Partner
San Francisco
-
-
Venture Partner
Saint Vincent
-
-
Venture Partner
United States
-
-
Venture Partner
United States
-
Venture Partner
Seattle
-
-
Venture Partner
-
-
-
Venture Partner
-
-
-
Principal
-
-
-

Co-investors of KittyHawk Ventures

Over the past 8 years, 57 investors have co-invested in KittyHawk Ventures's portfolio companies. This includes funds and angels.

Recent News related to KittyHawk Ventures

View all news related to KittyHawk Ventures

FAQs about KittyHawk Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford